Frank Rimerman Advisors LLC Purchases 28 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Frank Rimerman Advisors LLC raised its position in Mettler-Toledo International Inc. (NYSE:MTD) by 7.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 408 shares of the medical instruments supplier’s stock after purchasing an additional 28 shares during the period. Frank Rimerman Advisors LLC’s holdings in Mettler-Toledo International were worth $499,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. SBI Securities Co. Ltd. purchased a new stake in shares of Mettler-Toledo International in the fourth quarter worth $33,000. Blue Trust Inc. raised its holdings in shares of Mettler-Toledo International by 70.8% in the 4th quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier’s stock valued at $50,000 after acquiring an additional 17 shares in the last quarter. Whipplewood Advisors LLC purchased a new stake in shares of Mettler-Toledo International in the 4th quarter valued at about $54,000. Sound Income Strategies LLC boosted its position in shares of Mettler-Toledo International by 4,500.0% during the 4th quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock valued at $56,000 after acquiring an additional 45 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its holdings in shares of Mettler-Toledo International by 14.3% during the fourth quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock worth $78,000 after purchasing an additional 8 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now owns 6 shares in the company, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Christian Magloth sold 790 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at $964,248.46. This represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Analysts Set New Price Targets

MTD has been the topic of several research analyst reports. Wells Fargo & Company upped their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, February 10th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating on the stock. Robert W. Baird upped their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Citigroup decreased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. Finally, Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,380.50.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,231.32 on Monday. Mettler-Toledo International Inc. has a one year low of $1,142.91 and a one year high of $1,546.93. The firm’s 50 day simple moving average is $1,295.03 and its two-hundred day simple moving average is $1,316.72. The stock has a market capitalization of $25.75 billion, a P/E ratio of 30.38, a PEG ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, equities analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.